1-3 of 3
Lisa Eidenschink Brodersen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Risk Markers Define Risk of Relapse in Myeloid Leukemia of Down syndrome Beyond Measurable Residual Disease

Open Access
Jason N Berman, Anupam Verma, Shelton A. Viola, Todd Alonzo, Yi-Cheng Wang, Lisa Eidenschink Brodersen, Michael R Loken, Amy K. Beckman, Betsy A Hirsch, Susana Raimondi, Karen M. Chisholm, Xiaotu Ma, Rhonda E. Ries, Soheil Meshinchi, Alan S Gamis, Reuven J Schore, Jeffrey W. Taub, E Anders Kolb, Todd M Cooper, Johann K. Hitzler
Journal: Blood Advances
Blood Adv bloodadvances.2025017837.
https://doi.org/10.1182/bloodadvances.2025017837
Published: 2025
Includes: Supplemental data
Journal Articles

Therapeutic targeting of PRAME with mTCR CAR T cells in acute myeloid leukemia

Free
Danielle C. Kirkey, Anisha M. Loeb, Sommer Castro, Cyd Nourigat McKay, LaKeisha Perkins, Laura Pardo, Amanda R. Leonti, Thao T. Tang, Michael R. Loken, Lisa Eidenschink Brodersen, Keith R. Loeb, David A. Scheinberg, Quy Le, Soheil Meshinchi
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1178–1189.
https://doi.org/10.1182/bloodadvances.2022008304
Published: 2023
Includes: Supplemental data
Journal Articles

Morphologic remission status is limited compared to ΔN flow cytometry: a Children’s Oncology Group AAML0531 report

Free
Lisa Eidenschink Brodersen, Robert B. Gerbing, M. Laura Pardo, Todd A. Alonzo, Dana Paine, Wayne Fritschle, Fan-Chi Hsu, Jessica A. Pollard, Richard Aplenc, Samir B. Kahwash, Betsy Hirsch, Susana Ramondi, Denise Wells, E. Anders Kolb, Alan S. Gamis, Soheil Meshinchi, Michael R. Loken
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5050–5061.
https://doi.org/10.1182/bloodadvances.2020002070
Published: 2020
Includes: Supplemental data